Fonte: Science Advances. Unidades: FMRP, FCFRP
Assuntos: INFECÇÕES RESPIRATÓRIAS, COVID-19, ADJUVANTES IMUNOLÓGICOS, INFLAMAÇÃO
ABNT
ALMEIDA, Leticia de et al. Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection. Science Advances, v. 8, n. 37, 2022Tradução . . Disponível em: https://doi.org/10.1126/sciadv.abo5400. Acesso em: 01 nov. 2024.APA
Almeida, L. de, Silva, A. L. N., Rodrigues, T. S., Oliveira, S., Ishimoto, A. Y., Seribelli, A. A., et al. (2022). Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection. Science Advances, 8( 37). doi:10.1126/sciadv.abo5400NLM
Almeida L de, Silva ALN, Rodrigues TS, Oliveira S, Ishimoto AY, Seribelli AA, Becerra A, Andrade WA, Ataíde MA, Caetano CCS, Sá KSG de, Pelisson N, Martins RB, Souza J de P, Arruda E, Batah SS, Castro R, Frantz FG, Cunha FQ, Cunha TM, Fabro AT, Cunha LD, Louzada-Junior P, Oliveira RDR de, Zamboni DS. Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection [Internet]. Science Advances. 2022 ; 8( 37):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1126/sciadv.abo5400Vancouver
Almeida L de, Silva ALN, Rodrigues TS, Oliveira S, Ishimoto AY, Seribelli AA, Becerra A, Andrade WA, Ataíde MA, Caetano CCS, Sá KSG de, Pelisson N, Martins RB, Souza J de P, Arruda E, Batah SS, Castro R, Frantz FG, Cunha FQ, Cunha TM, Fabro AT, Cunha LD, Louzada-Junior P, Oliveira RDR de, Zamboni DS. Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection [Internet]. Science Advances. 2022 ; 8( 37):[citado 2024 nov. 01 ] Available from: https://doi.org/10.1126/sciadv.abo5400